Brief: Tianda Pharmaceuticals Says Unit Granted Drug Registration Approval Of Ibuprofen Suspension By NMPA
11/06/2024 10:55
June 11 (Reuters) - Tianda Pharmaceuticals Ltd
0455.HK :
* UNIT GRANTED DRUG REGISTRATION APPROVAL OF IBUPROFEN
SUSPENSION
BY NMPA
Further company coverage: 0455.HK
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Tianda Pharmaceuticals
See all newsBrief: Tianda Pharmaceuticals Says Loss Attributable Expected To Increase To Hk$61 Million For FY
Brief: Tianda Pharmaceuticals Clarifies On Fraudulent Fund Raising Scams
Brief: Tianda Pharmaceuticals Sees Loss Attributable For Interim Period Increase To Not Less Than HK$27 Mln
Brief: Tianda Pharmaceuticals Says Unit Granted Drug Registration Approval Of Ibuprofen Suspension By NMPA
Brief: Tianda Pharmaceuticals Says Drug Registration Approval Of "Nicorandil For Injection" By NMPA